GSK plc

SEC CIK: 0001131399
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by GSK plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q2 2026): 3,220,627
Value: $175.7M
% of portfolio: 29.2%
Quarters held: 3; Since Q4 2025

Holdings of CRSP by GSK plc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	3,220,627	$175.7M	29.2%	00.0%	Unchanged	Holders
Q1 2026	3,220,627	$153.2M	25.6%	00.0%	Unchanged	Holders
Q4 2025	3,220,627	$168.9M	21.1%	–	No prior filing	Holders